No arrhythmias triggered in heart failure patients upon caffeine intake

20-10-2016 • Zuchinali P, et al, JAMA, 2016
The acute ingestion of high doses of caffeine in 51 HF patients did not induce arrhythmias neither at rest, nor during exercise.  Read more
News • 19-10-2016

AHA Scientific Statement gives guidance on how to limit drug-drug-interactions with statins

Clinically significant drug-drug-interactions with statins and other medications given to treat CVD may be prevented. This document gives recommendations on how to minimise adverse effects. Read more
News • 17-10-2016

AHA panel gives in-depth evaluation of link between hypertension and dementia

The panel considers the evidence insufficient to formulate evidence-based recommendations, but personalised BP management is probably the wisest approach to safeguard cerebrovascular health. Read more

Lower mortality rate with 25 years of intensive lipid-lowering therapy of CAD

10-10-2016 • Zhao XQ et al., J Clin Lipidol 2016
Intensive lipid-lowering therapy for 25 years was associated with significant reductions in CV and total mortality in men with increased LDL-C levels and established coronary artery disease. Read more
News • 28-9-2016

Better sleep for better cardiometabolic health

AHA issued a Scientific Statement in which they review evidence on the relation between too short and too long sleep duration and CV risk, and call for more awareness in clinical practice. Read more

CV incidence decreased with tea consumption

26-9-2016 • Miller PE, et al, Am J Med, 2016
Both prevalence and progression of coronary artery calcium and number of CV events were decreased when drinking more than one cup of tea a day.  Read more
News • 20-10-2016

EPCCS Practical Guidance on Heart Failure Diagnosis and Management in Primary Care

Based on the Heart Failure session and discussion during the 8th EPCCS Annual Meeting in Prague, this guidance document was written to help physicians diagnose and manage heart failure in their primary care practice. Read more

CV morbidity and mortality enhanced with higher pulse pressure

18-10-2016 • McEvoy JW, et al, JACC, 2016
Particularly when DBP was <60 mmHg and SBP above 120 mmHg, patients had higher troponin levels, more frequent CHD events and mortality. Read more

DOACs also beneficial for elderly AF and VTE patients

11-10-2016 • Sadlon AH, Swiss Med Wkly, 2016
Rivaroxaban, apixaban, dabigatran and edoxaban were superior to VKAs in a meta-analysis of 8 studies comprising elderly patients with atrial fibrillation or venous thromboembolism. Read more

Recurrent risk varies substantially in vascular patients: risk stratification can be improved

10-10-2016 • Kaasenbrood L, et al., Circulation 2016
There is substantial variation in the estimated 10-year risk of recurrent vascular events in patients with vascular disease that supports the need for optimisation of risk stratification of these patients. Read more

Patients at very high CV risk would benefit from stricter monitoring and adherence to guidelines

26-9-2016 • Heintjes E, et al., Curr res med opin 2016
Despite lipid-lowering therapy, a large proportion of patients with CV events and/or T2DM did not meet the less stringent Dutch LDL-c target (2.5 mmol/L), BP and HbA1c targets.
  Read more

Metabolic factors may identify individuals prone to develop statin-related diabetes

19-9-2016 • Kohli P et al., Am J Cardiol 2016
The diabetogenic impact of statin treatment is relatively modest, but is aggravated if plasma glucose, TG concentrations and BMI increase. Read more

Upcoming meetings

Meeting reports & resources

EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
EPCCS 2013 Report of 6th Annual EPCCS meeting held in London
All meeting reports...